medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2022, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (1)

Usefulness of therapeutic plasmapheresis in critical patients with organ dysfunction

Figueroa SJA, Rodríguez PLD, Mamposo VJC

Language: Spanish
References: 30
Page: 1-13
PDF size: 284.28 Kb.


ABSTRACT

Introduction: Therapeutic apheresis is the procedure that separates and removes plasma from whole blood, thus eliminating components considered pathogenic of a disease or its clinical manifestations.
Objectives: To analyze the general aspects of de application of the plasmapheresis technique as an alternative treatment in oncohematological patients wish organic dysfunction.
Methods: A bibliographic- documentary investigation was carried out on de subject The Scielo and Pubmed data bases were consulted. Analysis and synthesis of information: The technical aspects of plasmapheresis are described, based on its indication criteria, as well as the application of de technique in patients with organic dysfunction and its results in the evolution of the patient.
Conclusions: With the use of the plasmapheresis technique improvement in clinical and laboratory parameters was found in the majority of organ dysfunction patients upon discharge from the intensive care unit.


REFERENCES

  1. Schwartz J, Padmanabhan A, Aqui N, Ohlow MA, Cozzi E. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher.2016;31:149-62.

  2. Ipe TS, Pham HP, Williams LA 3rd. Critical updates in the 7th edition of the American Society for Apheresis guidelines. J ClinApher. 2018;33(1):78-94.

  3. Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study BMJ 2012;345:e4565 DOI: https://10.1136/bmj.e4565

  4. Greinacher A, Friesecke S, Abel P,Zhou F. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolyticuraemic syndrome: a prospective trial. Lancet.2018;378:1166-73.

  5. Rimmer E, Houston BL, Kumar A,Kellum JA. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and metaanalysis. Crit Care.2018;18:699.

  6. Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41:2209-20.

  7. Chang T, Tu YK, Lee CT, Lauer B. Effects of Polymyxin B Hemoperfusion on Mortality in Patients with Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis. Crit Care Med. 2017;45:e858-64.

  8. Fortenberry JD, Nguyen T, Grunwell JR Dale RC, Gorman MP. Thrombocytopenia-Associated Multiple Organ Failure (TAMOF) Network Study Group. Therapeutic Plasma Exchange in Children with Thrombocytopenia-Associated Multiple Organ Failure: The Thrombocytopenia-Associated Multiple Organ Failure Network Prospective Experience. Crit Care Med. 2019;47:e173-e81.

  9. Winters JL, Cooper LT, Ratcliffe NR, McLeod B. National Heart, Lung, and Blood Institute. State of the science symposium in therapeutic apheresis-Therapeutic apheresis in cardiovascular disease. J ClinApher.2016;30:183-7.

  10. Ohlow MA, Brunelli M, Schreiber M, Lauer B. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry. J Cardiol. 2017;69(2):409-16.

  11. Cozzi E, Colpo A, De Silvestro G. The mechanisms of rejection in solid organ transplantation. TransfusApher Sci. 2017;56:498-505.

  12. Thompson C, Kneen R, Riordan A, Chang T, Tu YK. Encephalitis in children. Arch Dis Child.2018;97:150-61.

  13. Dale RC, Gorman MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges. CurrOpin Neurol. 2017;30:334-44.

  14. Llufriu S, Castillo J, Blanco Y, Nguyen T Kiss J Goldman J. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology. 2019;73(12):949-53.

  15. Balogun R, Kaplan A, Ward D, McLeod B. Clinical Applications of Therapeutic Apheresis. J ClinApher. 2015;25:250- 64.

  16. Ewald N Hardt P Hans-Ulrich K. Severe hypertriglyceridemia and pancreatitis: presentation and management. CurrOpinLipidol.2019;20:497-504.

  17. McLeod B. Evidence based therapeutic apheresis in autoimmune and other hemolytic anemia. CurrOpinHematol.2007;14:647-54.

  18. Ipe, T. S, Pham, H. P, & Williams, L. A. (2018). Critical updates in the 7th edition of the American Society for Apheresis guidelines. Journal of Clinical Apheresis,33(1),8-94. DOI: https://doi.org/10.1002/jca.21562

  19. Sánchez A, Ward D. Therapeutic Apheresis for Renal Disorders. Sem Dialysis.2018;25:119-31.

  20. Szczepiorkowski Z Winters J Bandarenko N. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence- Based Approach from the Apheresis Applications Committee of the American Society for Apheresis. J ClinApher.2017;25:83-177.

  21. Okafor C Ward D Mokrzycki M. Introduction and Overview of Therapeutic Apheresis. J ClinApher.2010;25:240-9.

  22. Winters JL. Apheresis Medicine State of art in 2017: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis. J ClinApher.2017;26(5):239-42.

  23. Dobke M, Hunt JL, Purdue GF, Baxter CR. Effect of plasma exchange therapy on circulating fibronectin in burned patients. J Burn Care Rehabil. 2020;6:239-42.

  24. Donati L, Signorini M, Busnach G, Noe L, Mazza E. Prophylactic plasma exchange in burn treatment. Int J Tissue React. 2020;9:215-8.

  25. Klein MB, Edwards JA, Kramer CB, Nester T, Heimbach DM, Gibran NS. The beneficial effects of plasma exchange after severe burn injury. J Burn Care Res. 2019;30:243-8.

  26. Kravitz M, Warden GD, Sullivan JJ, Saffle JR. A randomized trial of plasma exchange in the treatment of burn shock. J Burn Care Rehabil 1989;10:17-26.

  27. McManus WF. Is there a role for plasmapheresis/exchange transfusion in the treatment of the septic burn patient? J. Trauma2000;24:S137-45.

  28. Neff LP, Allman JM, Holmes JH. The use of therapeutic plasma exchange (TPE) in the setting of refractory burn shock. Burns 2010;36:372-8.

  29. Ninnemann JL, Stratta RJ, Warden GD, Saffle JR, Weber ME. The effect of plasma exchange on lymphocyte suppression after burn. Arch Surg 2020;119:33-8.

  30. Pham TN, Cancio LC, Gibran NS. American Burn Association practice guidelines burn shock resuscitation. J BurnCare Res 2018;29:257-66.




2020     |     www.medigraphic.com